摘要
目的:观察欣普贝生联合催产素对足月妊娠引产的临床效果。方法:将在本院足月妊娠引产的140例人员分为三组,分别是欣普贝生1枚塞阴道引产组(60例),小剂量催产素组(40例),欣普贝生联合催产素产组(40例),观察用药后24h内足月妊娠引产临产时间和足月妊娠引产分娩成功率比较。结果:欣普贝生组足月妊娠引产24h内临产成功率为53.33%,分娩成功率83.33%;小剂量催产素组分别为30.0%和52.5%,欣普贝生联合催产素产组分别为70.0%和97.5%,三组两两相比较,差异具有统计学意义(P<0.05)。结论:欣普贝生联合催产素用于足月妊娠分娩引产可以缩短临床临产时间和提高成功分娩的几率,效果优于单独使用欣普贝生或者催产素,且用药安全,值得临床使用。
Objective： To observe the clinical effect of dinoprostone suppositories combined oxytocin for odinopoeia of full-term pregnancy delivery. Method： 140 cases were divided into 3 groups as dinoprostone suppositories group, oxytocin group, dinoprostone suppositories combined oxytoein group. Labor time and delivery success rate of all groups after 24 h of medication were observed and compared. Result： Parturient success rate within 24 h and delivery success rate o~ dinoprostone suppositories group were 53.33% and 83.33%, and oxytocin group were 30% and 52.5%, and dinoprostone suppositories combined oxytocin group were 70% and 97.5% （P〈0.05） . Conclusion： Dinoprostone suppositories combined oxytocin for odinopoeia of full-term pregnancy delivery can shorten parturient time and increase delivery success rate. It is superior to single use of dinoprostone suppositories or oxytoein and it＇ s safe, worth of being popularized in clinical work.
出处
《中国医学创新》
CAS
2013年第15期64-65,共2页
Medical Innovation of China
关键词
欣普贝生
催产素
分娩成功
Dinoprostone Suppositories
Oxytocin
Delivery Success
